Keryx Biopharmaceuticals Inc
KERX
KERX was delisted on the 12th of December, 2018.
157 hedge funds and large institutions have $1.19B invested in Keryx Biopharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 73 increasing their positions, 28 reducing their positions, and 24 closing their positions.
161% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 28
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
46% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 24
10% more capital invested
Capital invested by funds: $1.08B → $1.19B (+$107M)
7% more funds holding
Funds holding: 147 → 157 (+10)
14% less call options, than puts
Call options by funds: $10.5M | Put options by funds: $12.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$52.5M |
| 2 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$24.7M |
| 3 |
FC
Finepoint Capital
Boston,
Massachusetts
|
+$20.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$17.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$10.4M |
| 2 |
PC
PointState Capital
New York
|
-$7.08M |
| 3 |
DM
Deerfield Management
New York
|
-$5.37M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$5.17M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$4.68M |
KERX Hedge Fund Activity: Q1 2015 in Review
157 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q1 2015, worth a combined $1.19B — up 9.9% from $1.08B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new KERX positions and 24 closed out — a net gain of 11 holders — while 73 added to existing stakes and 28 trimmed.
The largest buyer was Baupost Group, adding an estimated $52.5M. The largest seller was Eagle Asset Management, cutting an estimated $10.4M.
- 157 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q1 2015, up from 147 in Q4 2014.
- Funds reported $1.19B of Keryx Biopharmaceuticals Inc stock for Q1 2015, up 9.9% quarter-over-quarter.
- 35 funds opened new Keryx Biopharmaceuticals Inc positions in Q1 2015 and 24 closed out, a net change of +11 holders.
- The largest Keryx Biopharmaceuticals Inc buyer in Q1 2015 was Baupost Group, an estimated $52.5M added.
- The largest Keryx Biopharmaceuticals Inc seller in Q1 2015 was Eagle Asset Management, an estimated $10.4M sold.
Based on aggregated 13F filings for Q1 2015.